申请人:Mead Johnson & Company
公开号:US04517188A1
公开(公告)日:1985-05-14
1-(4-Pyrimidinyloxy)-3-(hetarylalkylamino)-2-propanols are cardiovascular agents having a range of vasodilator and adrenergic beta-receptor blocking activities making these compounds useful anti-hypertensive agents. Preferred compounds bear a hydrazino or hydrazono substituent in the 2- position of the pyrimidine ring.
1-(4-吡啶氧基)-3-(杂环烷基氨基)-2-丙醇是心血管药物,具有一系列血管扩张剂和肾上腺素β受体阻滞活性,使这些化合物成为有用的降压药物。首选化合物在嘧啶环的2-位置带有肼基或肼酰基取代基。